Clinical trial
Evaluation of Physician and Patient Knowledge of Safety and Safe Use Information for Aflibercept in Europe: An Observational Postauthorisation Study
NCT02615496 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Physician and Patient Knowledge of Safety and Safe Use Information for Aflibercept in Europe: An Observational Postauthorisation Study
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 7, 2015
- Completion date
- January 31, 2017
- Enrollment
- 716 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.